Log In
Print
BCIQ
Print
Print this Print this
 

ApoCell

  Manage Alerts
Collapse Summary General Information
Company Enlivex Therapeutics Ltd.
DescriptionAutologous or donor cells manipulated ex vivo to begin early stages of apoptosis
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat graft-versus-host disease (GvHD)
Regulatory Designation

U.S. - Orphan Drug (Treat graft-versus-host disease (GvHD))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today